The Hear Clear Study
Hearing Aid Benefit in Adults With Self-Reported Hearing Difficulty Yet Normal Pure-Tone Audiograms (Duke sIRB)
2 other identifiers
interventional
125
1 country
2
Brief Summary
The purpose of this study is to determine if hearing aid use helps adults with "normal" hearing on clinical hearing tests (i.e., pure-tone audiogram), but who report hearing trouble in everyday life. Another purpose is to understand what factors and hearing aid features provide the most help for these people.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2027
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2026
CompletedFirst Posted
Study publicly available on registry
September 17, 2026
CompletedStudy Start
First participant enrolled
January 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2030
Study Completion
Last participant's last visit for all outcomes
May 1, 2030
September 21, 2026
September 1, 2026
3.3 years
September 11, 2026
September 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Revised Hearing Handicap Inventory (RHHI)
18-item questionnaire that assesses self-perceived hearing difficulty associated with social and emotional situations and is considered a hearing-related quality of life measure. Higher scores indicate MORE hearing difficulty. Administered unaided and aided. Scores range from 0 - 72.
Baseline (unaided), 4 weeks (aided with intervention 1), 4 weeks (after wash-out period, and unaided), and 4 weeks (aided with intervention 2)
Secondary Outcomes (2)
Abbreviated Profile of Hearing Aid Benefit (APHAB)
Baseline (unaided), 4 weeks (aided with intervention 1), 4 weeks (after wash-out period, and unaided), and 4 weeks (aided with intervention 2)
Words in Noise (WIN) Test
Baseline (unaided), 4 weeks (aided with intervention 1), 4 weeks (after wash-out period, and unaided), and 4 weeks (aided with intervention 2)
Study Arms (2)
Open-dome receiver-in-canal hearing aids
EXPERIMENTALAir-conduction receiver-in-canal (RIC) hearing aids with open domes, which have holes or vents that let natural sound and air pass into the ear canal.
Closed-dome receiver-in-canal hearing aids
EXPERIMENTALAir-conduction receiver-in-canal (RIC) hearing aids with closed domes, which have solid rubber with tiny or no vents to seal the ear.
Interventions
Participants will be randomly assigned to either the open dome or closed dome group (Factor 1). Participants will then obtain their first treatment arm with a random assignment of either an SNR neutral (SNR-) or SNR enhanced (SNR+) hearing aid fitting (Factor 2). They will return to the lab for testing prior to crossing over to the second arm (the other SNR configuration: SNR- or SNR+). The SNR+ setting contains features to improve the signal-to-noise ratio of the sound to optimize speech over noise through the hearing aids.
Participants will be randomly assigned to either the open dome or closed dome group (Factor 1). Participants will then obtain their first treatment arm with a random assignment of either an SNR neutral (SNR-) or SNR enhanced (SNR+) hearing aid fitting (Factor 2). They will return to the lab for unaided baseline testing prior to crossing over to the second arm (the other SNR configuration: SNR- or SNR+). The SNR- setting contains focuses on improving audibility of sounds through the hearing aids.
Eligibility Criteria
You may qualify if:
- Are adults (≥18 years) presenting with "normal hearing" (pure-tone thresholds ≤25 dB HL from 250-4000 Hz) but hearing trouble (≥20 points on RHHI questionnaire)
- Are willing to try amplification (i.e., hearing aids) for the first time
- Can Read/write in American English
- Have access to email, internet, and phone
You may not qualify if:
- Participants with self-reported otologic history (e.g., ear surgery, ototoxic medications, middle-ear dysfunction, holes in ear drums)
- Have moderate to severe traumatic brain injury
- Have bothersome tinnitus as their primary complaint
- Have a health condition that would interfere with study participation (e.g., dementia/cognitive disorder, blindness)
- Prior hearing aid use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Duke University Medical Center
Durham, North Carolina, 27710, United States
The Ohio State University
Columbus, Ohio, 43210, United States
Related Publications (3)
Roup CM, Post E, Lewis J. Mild-Gain Hearing Aids as a Treatment for Adults with Self-Reported Hearing Difficulties. J Am Acad Audiol. 2018 Jun;29(6):477-494. doi: 10.3766/jaaa.16111.
PMID: 29863462BACKGROUNDSingh J, Doherty KA. Use of a Mild-Gain Hearing Aid by Middle-Age Normal-Hearing Adults Who Do and Do Not Self-Report Trouble Hearing in Background Noise. Am J Audiol. 2020 Sep 3;29(3):419-428. doi: 10.1044/2020_AJA-19-00051. Epub 2020 Jun 30.
PMID: 32603602BACKGROUNDMealings K, Valderrama JT, Mejia J, Yeend I, Beach EF, Edwards B. Hearing Aids Reduce Self-Perceived Difficulties in Noise for Listeners With Normal Audiograms. Ear Hear. 2024 Jan-Feb 01;45(1):151-163. doi: 10.1097/AUD.0000000000001412. Epub 2023 Aug 9.
PMID: 37553897BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sherri L Smith, Au.D., Ph.D.
Duke University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2026
First Posted
September 17, 2026
Study Start (Estimated)
January 1, 2027
Primary Completion (Estimated)
May 1, 2030
Study Completion (Estimated)
May 1, 2030
Last Updated
September 21, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- 1 year after the main publication or as required by NIH policy
- Access Criteria
- Researchers interested in the study analytic dataset will request permission for use with justification for access.
Investigators will share the de-identified analytic dataset and associated metadata as required by NIH policy.